For the 30th edition of ECCMID, we would like to highlight 30 outstanding young scientists 30 years of age or younger. ZJE post-doctor, Dr. Prasanth Manohar is one of the awardees and the only one in China.
Prasanth Manohar博士是一名“90后”，目前在ZJE的Sebastian Leptihn研究员实验室从事博士后研究。于印度韦洛尔理工学院（VIT）取得了博士学位，在博士期间，他获得欧盟INNO Indigo项目支持的“青年科学家奖”和印度政府的“CSIR高级研究奖学金”。他的研究方向是噬菌体生物学、噬菌体治疗和抗生素耐药性。
Dr. Prasanth Manohar is working as a post-doctor in Dr Sebastian Leptihn’s lab in ZJE. He completed his Ph.D in Vellore Institute of Technology (VIT), Vellore, India, during which he was awarded with 'Young scientist award' from INNO Indigo projects, European Union and 'CSIR-Senior Research Fellowship' from Government of India. His research interests are bacteriophage biology, phage therapy and antibiotic resistance.
When asked why came to China for research, he mentioned that China is one of the fastest growing economy in the world withhands-on-use latest technologies, and there are substantial research funding sources available to meet the global needs that eventually supports the scientists to do innovation. Additionally, he loves Chinese people and the life in Haining has been pleasant.
During the COVID-19 outbreak, China carries out strict and effective prevention and control management. Therefore, Dr. Prasanth Manohar and his family still stay in India and waiting for new guideline. As a scientist in close area, Dr. Prasanth tells us that compared with SARS and MERS, covid-19 has lesser fatality rate but rapid transmission within the population. Being pandemic, countries with minimal health aids needs to be more cautious and such global emergency can only be controlled by public support. He stresses that 'prevention is better than cure'.
When it comes to future plan, Dr. Prasanth precisely states that he wants to become one of the reputed scientists in the field of phage therapy and he is working towards bringing phage therapy into a reality to treat antibiotic resistant infections.
Since its founding in 1983, ESCMID has evolved to become Europe’s leading society in clinical microbiology and infectious diseases with members from all European countries and all continents. For more than 30 years, ESCMID has been an influential component in the professional lives of microbiologists and infectious disease specialists and now reaches more than 8,500 individual and 30,000 affiliated members around the world.
ECCMID held by ECCIM, has become one of the most comprehensive and influential congresses in the field of infection and an exciting networking place bringing together >13,000 colleagues from all over the world. The scientific programme is built by the ECCMID Programme Committee, and independent group of experts representing all disciplines related to clinical microbiology and infectious diseases. The programme is built in two phases, based on submitted session proposals or submitted abstracts.